FR2259613A2 - - Google Patents
Info
- Publication number
- FR2259613A2 FR2259613A2 FR7503262A FR7503262A FR2259613A2 FR 2259613 A2 FR2259613 A2 FR 2259613A2 FR 7503262 A FR7503262 A FR 7503262A FR 7503262 A FR7503262 A FR 7503262A FR 2259613 A2 FR2259613 A2 FR 2259613A2
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/728,189 US4055756A (en) | 1975-02-03 | 1976-09-30 | Image coder-decoder using a matrix transform with weighted contribution of several points of the image to the formation of one point of the transform |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB501574A GB1460348A (en) | 1974-02-04 | 1974-02-04 | Quinazoline derivativesa |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FR2259613A2 true FR2259613A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1975-08-29 |
Family
ID=9788143
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7503262A Pending FR2259613A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1974-02-04 | 1975-02-03 |
Country Status (5)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0200356D0 (sv) * | 2002-02-05 | 2002-02-05 | Astrazeneca Ab | Novel use |
| GB0324763D0 (en) | 2003-10-23 | 2003-11-26 | Oxagen Ltd | Use of compounds in therapy |
| CA2658496A1 (en) | 2006-07-22 | 2008-01-31 | Oxagen Limited | 2-{5-fluoro-2-methyl-3-[2-(phenylsulfonyl)benzyl]-1h-indol-yl} acetic acid derivatives and esters thereof having crth2 antagonist activity |
| SI2250161T1 (sl) | 2008-01-18 | 2014-04-30 | Atopix Therapeutics Limited | Spojine, ki imajo aktivnost crth2 antagonista |
| EP2240444A1 (en) | 2008-01-22 | 2010-10-20 | Oxagen Limited | Compounds having crth2 antagonist activity |
| US20100022613A1 (en) | 2008-01-22 | 2010-01-28 | Oxagen Limited | Compounds Having CRTH2 Antagonist Activity |
| GB201322273D0 (en) | 2013-12-17 | 2014-01-29 | Atopix Therapeutics Ltd | Process |
-
1974
- 1974-02-04 GB GB501574A patent/GB1460348A/en not_active Expired
-
1975
- 1975-01-07 ZA ZA00750134A patent/ZA75134B/xx unknown
- 1975-01-10 AU AU77240/75A patent/AU7724075A/en not_active Expired
- 1975-02-03 BE BE153011A patent/BE825128R/xx active
- 1975-02-03 FR FR7503262A patent/FR2259613A2/fr active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU7724075A (en) | 1976-07-15 |
| GB1460348A (en) | 1977-01-06 |
| BE825128R (fr) | 1975-08-04 |
| ZA75134B (en) | 1976-01-28 |